Matribhumi Samachar English
First Hydration Formula Powered by VINIA’s Blood Flow Technology Enters the $13 Billion U.S. Electrolyte Market Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – December 3, 2025) – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology platform, announces the …
Read More »BioHarvest Sciences Reports First Quarter 2025 Financial Results
First Quarter Revenues Grew 47% to $7.9 Million, Exceeding Management Guidance Rehovot, Israel–(Newsfile Corp. – May 15, 2025) – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the first quarter …
Read More »BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results
Fourth Quarter Revenues Grew 62% to $7.3 Million, Exceeding Prior Management Guidance, with Full Year Revenues Increasing 99% Year-Over-Year to $25.2 Million CDMO Division Secures Anchor Partnership with Tate & Lyle to Develop Next Generation of Plant-Based Sweeteners Rehovot, Israel–(Newsfile Corp. – March 31, 2025) – BioHarvest Sciences Inc. (NASDAQ: …
Read More »BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time
Rehovot, Israel–(Newsfile Corp. – March 17, 2025) – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2024 after market close …
Read More »BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – March 6, 2025) – BioHarvest Sciences Inc. (NASDAQ: BHST) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to attend the 37th Annual Roth Conference taking place on March 16-18, 2025. CEO …
Read More »BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells
Non-Alcoholic Fatty Liver Disease (NAFLD) Affects 30-40% of U.S. Adults, Driving Significant Market Need for BioHarvest’s Future Olive Cell Product Targeting Liver Health Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – March 4, 2025) – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented …
Read More »BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD
Commercial success of VINIA validates the power of BioHarvest’s patented Botanical Synthesis technology to produce valuable plant-based Compounds at industrial scale Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – February 18, 2025) – BioHarvest Sciences Inc., (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical …
Read More »CSE Bulletin: Delist – BioHarvest Sciences Inc. (BHSC)
Toronto, Ontario–(Newsfile Corp. – Le 13 février/February 2025) – At the request of the company, BioHarvest Sciences Inc. will be delisted from the CSE effective market close on February 14, 2025. BioHarvest Sciences will continue to trade on the Nasdaq. _________________________________ À la demande de la société, BioHarvest Sciences Inc. …
Read More »BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – February 12, 2025) – BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the WeBull Consumer Stocks Virtual Webinar …
Read More »